Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 23.13B | 23.48B | 23.07B | 16.82B | 10.44B |
Gross Profit | 3.93B | 4.17B | 4.35B | 4.39B | 2.21B |
EBITDA | 3.38B | 3.75B | 4.27B | 3.83B | 1.82B |
Net Income | 1.46B | 1.19B | 1.81B | 1.77B | 524.15M |
Balance Sheet | |||||
Total Assets | 32.52B | 29.13B | 27.87B | 25.51B | 20.96B |
Cash, Cash Equivalents and Short-Term Investments | 895.06M | 1.25B | 1.48B | 906.19M | 698.13M |
Total Debt | 13.07B | 11.76B | 12.71B | 11.93B | 9.94B |
Total Liabilities | 20.00B | 18.62B | 18.30B | 17.55B | 14.53B |
Stockholders Equity | 8.96B | 7.69B | 6.89B | 5.69B | 4.53B |
Cash Flow | |||||
Free Cash Flow | -1.52B | 1.86B | 612.63M | -1.11B | -2.23B |
Operating Cash Flow | 3.35B | 5.33B | 4.38B | 2.75B | 1.70B |
Investing Cash Flow | -4.29B | -3.47B | -3.72B | -3.73B | -3.90B |
Financing Cash Flow | 665.77M | -2.16B | -82.18M | 1.19B | 2.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | HK$9.13B | 7.94 | 10.52% | 4.39% | -4.50% | 58.32% | |
79 Outperform | HK$7.11B | 4.26 | 17.58% | 4.96% | -3.45% | 20.63% | |
73 Outperform | HK$9.68B | 8.33 | 5.83% | 6.27% | -9.71% | -56.34% | |
69 Neutral | HK$1.06B | 11.51 | 4.75% | 2.12% | -13.75% | -56.14% | |
58 Neutral | HK$16.58B | 4.52 | -5.52% | 5.28% | -3.57% | -61.41% | |
54 Neutral | HK$1.03B | 14.10 | 2.75% | 3.42% | -11.89% | -69.45% | |
49 Neutral | HK$2.03B | 3.41 | 11.49% | ― | 47.32% | 492.76% |
China XLX Fertiliser Ltd. announced that all resolutions proposed at their Annual General Meeting on June 20, 2025, were passed. Key resolutions included the adoption of financial statements, declaration of a dividend, re-election of directors, re-appointment of auditors, and approval of share repurchase and issue mandates. These decisions are expected to strengthen the company’s governance and financial strategies, potentially enhancing shareholder value.
China XLX Fertiliser Ltd. announced changes in its joint company secretaries, authorised representative, and process agent in Hong Kong, effective from June 16, 2025. Ms. Leung Kwan Wai and Ms. Lin Moi Heyang have resigned from their roles, and Mr. Man Yun Wah and Ms. Cheok Hui Yee have been appointed in their places. These changes are part of the company’s compliance with Singaporean and Hong Kong regulations, ensuring continuity and effective communication within the company’s operations.
China XLX Fertiliser Ltd. has announced a change in the composition of its nomination committee, appointing Ms. Yan Yunhua as a member. This change aligns with amendments to the Listing Rules and Corporate Governance Code, effective 1 July 2025, and aims to enhance the board’s effectiveness and diversity, thereby improving the company’s corporate governance standards.
China XLX Fertiliser Ltd. has announced the roles and functions of its board of directors, highlighting the strategic and operational responsibilities of each member. This announcement underscores the company’s commitment to structured governance and may influence its strategic direction and operational efficiency.
China XLX Fertiliser Ltd. has announced the terms of reference for its Nomination Committee, effective from June 13, 2025. The committee will be composed mainly of independent non-executive directors, with a focus on diversity by including at least one member of a different gender. This move is expected to enhance corporate governance and ensure a balanced representation in the company’s decision-making processes.
In the first quarter of 2025, China XLX Fertiliser Ltd. experienced a fluctuating market with initial declines in fertiliser prices followed by a rebound driven by seasonal demand and export expectations. Despite a year-on-year decrease in gross profit margin, the company saw a quarter-on-quarter improvement, indicating recovery. Revenue increased slightly due to new production capacity and effective expense control, including a reduction in finance costs. The company managed to enhance working capital efficiency and profit potential by replacing high-interest loans.
China XLX Fertiliser Ltd. has announced that its board of directors will meet on May 16, 2025, to consider and approve the unaudited first quarterly results for the period ending March 31, 2025. This meeting is significant as it will provide insights into the company’s financial performance and could impact its market positioning and stakeholder interests.
China XLX Fertiliser Ltd. has announced a final cash dividend of RMB 0.26 per share for the financial year ending December 31, 2024, with the payment to be made in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.0569. This announcement reflects the company’s commitment to returning value to its shareholders and may influence its market positioning by demonstrating financial stability and shareholder confidence.
China XLX Fertiliser Ltd. has announced an update regarding its final cash dividend for the year ending December 31, 2024. The dividend is set at RMB 0.26 per share, with payment to be made in Hong Kong dollars at a rate of HKD 0.275 per share. The shareholders’ approval is scheduled for June 20, 2025, with the payment date on July 11, 2025. This announcement reflects the company’s financial health and commitment to returning value to its shareholders, potentially impacting investor confidence and market positioning.
China XLX Fertiliser Ltd. has announced proposed amendments to its constitution to allow for virtual and hybrid general meetings and electronic voting, aligning with regulatory changes in Hong Kong and Singapore. These amendments are considered beneficial for the company and its shareholders and will be subject to approval at the 2025 annual general meeting.
China XLX Fertiliser Ltd. has announced its 2025 Annual General Meeting, scheduled for June 20, 2025, in Henan Province, China. The meeting will cover key resolutions including the adoption of financial statements, declaration of dividends, approval of directors’ fees, re-election of directors, and re-appointment of auditors. Additionally, a special resolution will be considered to authorize the company to repurchase up to 10% of its issued shares, highlighting a strategic move to potentially enhance shareholder value and manage capital structure.